Genetic Control of the Immune Response. Mapping of the Ir-1 Locus
Overview
General Medicine
Affiliations
Eleven strains of mice bearing recombinant H-2 chromosomes derived from known crossover events between known H-2 types were immunized with a series of branched, multichain, synthetic polypeptide antigens [(T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L]. Results with nine of the eleven H-2 recombinants indicated that the gene(s) controlling immune response to these synthetic polypeptides (Ir-1) is on the centromeric or H-2K part of the recombinant H-2 chromosome. Results with two of the eleven recombinant H-2 chromosomes indicated that Ir-1 was on the telomeric or H-2D part of the recombinant H-2 chromosome. Both of these recombinants were derived from crossovers between the H-2K locus and the Ss-Slp locus near the center of the H-2 region. One of these recombinants, H-2(y), was derived from a known single crossover event. These results indicate that Ir-1 lies near the center of the H-2 region between the H-2K locus and the Ss-Slp locus. The results of a four-point linkage test were consistent with these results. In 484 offspring of a cross designed to detect recombinants between H-2 and Ir-1, only two putative recombinants were detected. Both of these recombinants were confirmed by progeny testing. Extensive analysis of one of them has shown that the crossover event occurred within the H-2 region. (Testing of the second recombinant is currently under way.) Thus, in the linkage test, recombinants between H-2 and Ir-1 are in fact intra-H-2 crossovers. These results permit assignment of Ir-1 to a position between the H-2K locus and the Ss-Slp locus.
Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?.
Kambayashi T, Laufer T Nat Rev Immunol. 2014; 14(11):719-30.
PMID: 25324123 DOI: 10.1038/nri3754.
The early history of Stanford Immunology.
Jones P, Herzenberg L Immunol Res. 2014; 58(2-3):164-78.
PMID: 24804901 DOI: 10.1007/s12026-014-8518-z.
A methods paper that led to much more.
Roopenian D J Immunol. 2013; 192(1):3-4.
PMID: 24363430 PMC: 4530560. DOI: 10.4049/jimmunol.1303010.
Glater E, Rockman M, Bargmann C G3 (Bethesda). 2013; 4(2):265-76.
PMID: 24347628 PMC: 3931561. DOI: 10.1534/g3.113.008649.
Molnarfi N, Schulze-Topphoff U, Weber M, Patarroyo J, Prodhomme T, Varrin-Doyer M J Exp Med. 2013; 210(13):2921-37.
PMID: 24323356 PMC: 3865476. DOI: 10.1084/jem.20130699.